Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Clinical Studies Validate Cancer Gene Delivery Platform: Landmark Publication Confirms Rexin-G Effectively Targets Metastatic Cancers
Epeius Biotechnologies stuns the medical and scientific communities with a dramatic demonstration of single-agent efficacy with its lead product, Rexin-G, for metastatic cancer. The landmark article (accessible online as of June 16, 2009 in Molecular Therapy, the Official Journal of The American Society of Gene Therapy, documents the results of two related studies using Rexin-G, a tumor-targeted anti-cancer agent designed to seek-out and destroy metastatic cancers that have spread throughout the body, while sparing normal cells and healthy tissues and organs. Following the FDA"s designation of Rexin-G as an Orphan Drug for the treatment of soft tissue sarcoma and osteosarcoma in 2008, the results of these two independent studies represent a major step toward gaining Accelerated Approval of Rexin-G for osteosarcoma in the United States.

Senate HELP Committee Approves Bill That Would Allow FDA To Regulate Tobacco
The Senate Health, Education, Labor and Pensions Committee on Wednesday voted 15-8 to approve a bill (S 982) giving FDA authority to regulate tobacco products, the Wall Street Journal reports. Under the bill, FDA could ban certain tobacco products, such as candy-flavored cigarettes, restrict tobacco advertising to black-and-white ads, and prohibit use of the terms "mild" and "low tar" (Yoest/Mundy, Wall Street Journal, 5/21). FDA also could limit the amount of nicotine in tobacco products, as well as enlarge warning labels. To pay for the new regulatory efforts, the bill would require all tobacco companies to pay a fee that would raise nearly $5.4 billion over the first 10 years. Committee members voted down a number of amendments:
News of the day
Nearly 1 In 10 Kids Report Cyber Bullying
New research shines a light on the phenomenon of "cyber bullying," suggesting that nearly 1 in 10 children are bullied through electronic means such as text messages, and girls are more likely to be victims than boys are.
Health Insurance

Family Drug Support's 'Stepping Stones To Success' Wins At The 2009 National Drug And Alcohol Awards

Family Drug Support"s Stepping Stones to Success program has won the 2009 National Drug and Alcohol Award for Excellence in Prevention and Community Education. The team was recognised during an awards ceremony at Parliament House in Canberra tonight when it was acknowledged for its contribution in raising community awareness around alcohol and drug problems. The other finalists in this category were FebFast and TAFE NSW"s Alcohol and Drug Strategy. The Australian Drug Foundation"s John Rogerson, acknowledged the effectiveness of the Stepping Stones program. "Stepping Stones is all about resilience and family support for those confronted by dependence." "There is a real groundswell of talent in the sector committed to minimising alcohol and drug harm. Australia can be confident of a comprehensive approach to prevention in the future. There is some great work going on in this sector," Mr Rogerson says. Stepping Stones to Success provides the opportunity for family members supporting alcohol and other drug dependents to find better ways of coping by increasing confidence and competency in managing drug issues. The Australian Drug Foundation is a strong supporter of Stepping Stones for Success and recognises Family Drug Support"s contribution to the community in the areas of alcohol and drug prevention and education. Australian Drug Foundation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009